Linden Thomas Advisory Services, LLC Neurocrine Biosciences Inc Transaction History
Linden Thomas Advisory Services, LLC
- $789 Billion
- Q4 2024
A detailed history of Linden Thomas Advisory Services, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 6,350 shares of NBIX stock, worth $730,377. This represents 0.11% of its overall portfolio holdings.
Number of Shares
6,350
Previous 6,061
4.77%
Holding current value
$730,377
Previous $698 Million
24.12%
% of portfolio
0.11%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
96.2MCall Options Held
380KPut Options Held
382K-
Black Rock Inc. New York, NY14.2MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$563 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$347 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$292 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...